A. Menarini International Licensing S.A. clinical trials
A subsidiary of Menarini Group
The registry lists 1 studies whose lead sponsor is A. Menarini International Licensing S.A.. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 9, 2026.
Registry sponsor names on this page
- A. Menarini International Licensing S.A.1 study
Something wrong with this grouping? Tell us on the Menarini Group page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Menarini Group studies →
- Phase 3 Clinical Study Evaluating Efficacy, Safety, and Tolerability of Obicetrapib Vs Bempedoic Acid to Treat Dyslipidemia in Adults With Primary Non-familial Hypercholesterolemia or Mixed Dyslipidemia at High to Very High Cardiovascular Risk, During a Treatment Period of Approximately 84 DaysRecruitingNCT07614958Phase 3
Sponsor listed in the registry: A. Menarini International Licensing S.A.